SEC Form 4 · accession 0001144204-15-017835
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel Ackerman
Officer — Chief Executive Officer · Director
Period of report
Mar 16, 2015
Accepted (ET)
Mar 23, 2015 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF1 | $0.41 | Mar 16, 2015 | A | 2,190,958 | A | — | Oct 25, 2020 | Common Stock | 2,190,958 | 2,190,958 | D |
| Option to purchase Common StockF2 | $0.41 | Mar 16, 2015 | A | 2,190,959 | A | — | Oct 25, 2020 | Common Stock | 2,190,959 | 2,190,959 | D |
| Option to purchase Common StockF3 | $0.41 | Mar 16, 2015 | A | 1,347,977 | A | — | Nov 5, 2013 | Common Stock | 1,347,977 | 1,347,977 | D |
| Option to purchase Common StockF4 | $0.41 | Mar 16, 2015 | A | 1,347,977 | A | — | Nov 5, 2013 | Common Stock | 1,347,977 | 1,347,977 | D |
| Option to purchase Common StockF5 | $0.41 | Mar 16, 2015 | A | 193,210 | A | — | Nov 5, 2013 | Common Stock | 193,210 | 193,210 | D |
| Option to purchase Common StockF6 | $0.41 | Mar 16, 2015 | A | 1,155,400 | A | — | Mar 16, 2015 | Common Stock | 1,155,400 | 1,155,400 | D |
Explanation of responses
- F1Fully vested upon grant.
- F2Fully vested upon grant.
- F3Vested as to 561,655 shares on grant; remainder vests quarterly over period ending on November 4, 2016, with the next vesting to occur on May 5, 2015.
- F4Vesting to occur upon completion of performance criteria that have not been set.
- F5Fully vested upon grant.
- F6Vested as to 288,850 shares on grant; remainder vests quarterly over period ending on November 4, 2015, with the next vesting to occur on May 5, 2015.